Ranch Capital Advisors Inc. Moderna, Inc. Transaction History

Ranch Capital Advisors Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $101,925 - $180,844	-861 Reduced 41.16%	1,231 $221,000
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $247,002 - $406,224	2,092 New	2,092 $247,000
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $159,648 - $240,692	-1,363 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $27,821 - $51,711	-220 Reduced 13.9%	1,363 $235,000
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $4,290 - $7,001	-19 Reduced 1.19%	1,583 $402,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $8,210 - $17,925	-37 Reduced 2.26%	1,602 $617,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $28,320 - $51,225	218 Added 15.34%	1,639 $385,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $45,418 - $77,367	416 Added 41.39%	1,421 $186,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $25,309 - $65,396	385 Added 62.1%	1,005 $104,000
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $11,719 - $31,600	395 Added 175.56%	620 $44,000
Q1 2020 May 12, 2020	BUY	$17.78 - $31.58 $4,000 - $7,105	225 New	225 $6,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.